TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX), a medical technology company focused on transforming organ transplant therapy, has announced its plans to release second quarter 2024 financial results on July 31, 2024, after market close. The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day to discuss the results. Investors can join the call by dialing (866) 807-9684 (domestic) or (412) 317-5415 (international) and requesting to join the TransMedics call. A live and archived webcast will be available on the company's investor relations website.

ANDOVER, Mass., July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the second quarter 2024 after market close on Wednesday, July 31, 2024. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (866) 807-9684 for domestic callers or (412) 317-5415 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.   

About TransMedics Group, Inc. 
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-second-quarter-2024-financial-results-on-july-31-2024-302199738.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) release its Q2 2024 financial results?

TransMedics (TMDX) will release its second quarter 2024 financial results on Wednesday, July 31, 2024, after market close.

What time is the TransMedics (TMDX) Q2 2024 earnings conference call?

The TransMedics (TMDX) Q2 2024 earnings conference call is scheduled for Wednesday, July 31, 2024, at 4:30 p.m. ET / 1:30 p.m. PT.

How can investors listen to TransMedics' (TMDX) Q2 2024 earnings call?

Investors can listen to TransMedics' (TMDX) Q2 2024 earnings call by dialing (866) 807-9684 for domestic callers or (412) 317-5415 for international callers and asking to join the TransMedics call. A live webcast will also be available on the company's investor relations website.

What does TransMedics (TMDX) specialize in?

TransMedics (TMDX) is a medical technology company that specializes in transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure.